Lingzhi Wang

Prof. Dr. Lingzhi Wang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LQLiansheng Qiao
Liansheng Qiao
BLBin Li
Bin Li
YCYankun Chen
Yankun Chen
LLLingling Li
Lingling Li
XCXi Chen
Xi Chen
YZYanling Zhang
Yanling Zhang
Adlay (Coix larchryma-jobi L.) was the commonly used Traditional Chinese Medicine (TCM) with high content of seed storage protein. The hydrolyzed bioactive oligopeptides of adlay have been proven to be anti-hypertensive effective components. However, the structures and anti-hypertensive mechanism of bioactive oligopeptides from adlay were not clear. To discover the definite anti-hypertensive oligopeptides from adlay, in silico proteolysis and virtual screening were implemented to obtain potential oligopeptides, which were further identified by biochemistry assay and molecular dynamics simulation. In this paper, ten sequences of adlay prolamins were collected and in silico hydrolyzed to construct the oligopeptide library with 134 oligopeptides. This library was reverse screened by anti-hypertensive pharmacophore database, which was constructed by our research team and contained ten anti-hypertensive targets. Angiotensin-I converting enzyme (ACE) was identified as the main potential target for the anti-hypertensive activity of adlay oligopeptides. Three crystal structures of ACE were utilized for docking studies and 19 oligopeptides were finally identified with potential ACE inhibitory activity. According to mapping features and evaluation indexes of pharmacophore and docking, three oligopeptides were selected for biochemistry assay. An oligopeptide sequence, NPATY (IC50 = 61.88 ± 2.77 µM), was identified as the ACE inhibitor by reverse-phase high performance liquid chromatography (RP-HPLC) assay. Molecular dynamics simulation of NPATY was further utilized to analyze interactive bonds and key residues. ALA354 was identified as a key residue of ACE inhibitors. Hydrophobic effect of VAL518 and electrostatic effects of HIS383, HIS387, HIS513 and Zn2+ were also regarded as playing a key role in inhibiting ACE activities. This study provides a research strategy to explore the pharmacological mechanism of Traditional Chinese Medicine (TCM) proteins based on in silico proteolysis and virtual screening, which could be beneficial to reveal the pharmacological action of TCM proteins and provide new lead compounds for peptides-based drug design.

13 January 2017 in Molecules
Verified
Journal Article
Open access
PDF file
BLBin Li
Bin Li
LQLiansheng Qiao
Liansheng Qiao
LLLingling Li
Lingling Li
YZYanling Zhang
Yanling Zhang
KLKai Li
Kai Li
YQYanjiang Qiao
Yanjiang Qiao
Our previous studies have shown that Coix glutelin pepsin hydrolysate can effectively inhibit angiotensin converting enzyme (ACE) activity in vitro. The main purpose of this study was to obtain potent anti-hypertensive peptides from Coix glutelin. The Coix glutelin hydrolysates (CGH) were prepared by pepsin catalysis and further separated by an ultrafitration (UF) system, gel filtration chromatography (GFC) and reversed-phase high performance liquid chromatography (RP-HPLC). As a result, the sub-fraction F5-3 had the highest ACE-inhibitory activity. Six ACE inhibitory peptides were identified using nano-liquid chromatography coupled to tandem mass spectrometry. The most potent peptide GAAGGAF (IC50 = 14.19 μmol·L−1) was finally obtained by further molecular simulation screening and a series of division and optimization. Single oral administration of synthesized GAAGGAF at 15 mg/kg body weight (BW) in spontaneously hypertensive rats (SHR) could reduce the systolic blood pressure (SBP) around 27.50 mmHg and the effect lasted for at least 8 h. The study demonstrated for the first time that the ACE inhibitory peptide GAAGGAF from Coix glutelin has a significant antihypertensive effect, and it could be a good natural ingredient for pharmaceuticals against hypertension and the related diseases.

1 May 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DSDuozhi Shi
Duozhi Shi
MCMeng Chen
Meng Chen
LLLijia Liu
Lijia Liu
QWQingqing Wang
Qingqing Wang
SLShuangyue Liu
Shuangyue Liu
RWRufeng Wang
Rufeng Wang

27 March 2017 in Molecules
Verified
Journal Article
Open access
PDF file
BLBin Li
Bin Li
LQLiansheng Qiao
Liansheng Qiao
LLLingling Li
Lingling Li
YZYanling Zhang
Yanling Zhang
KLKai Li
Kai Li
YQYanjiang Qiao
Yanjiang Qiao

31 May 2022 in European Food Research and Technology
Verified
Journal Article
Closed access
PDF file
PCPeiyao Chen
Peiyao Chen
YRYue Ren
Yue Ren
YZYueyuan Zhang
Yueyuan Zhang
YLYanan Liu
Yanan Liu
HSHaoyu Shi
Haoyu Shi
LWLingzhi Wang
Lingzhi Wang

17 August 2016 in CyTA - Journal of Food
Verified
Journal Article
Open access
LLLing-Ling Li
Ling-Ling Li
BLBin Li
Bin Li
HJHui-Fang Ji
Hui-Fang Ji
QMQun Ma
Qun Ma
LWLingzhi Wang
Lingzhi Wang
In this study, small molecular (≤3 kDa) Coix glutelin hydrolysate (CGH) was obtained by the method of enzymatic hydrolysis and then immunomodulatory activity was evaluated in vitro and in vivo. Stimulation index of mice splenocytes was increased in a dose-dependent manner after treated with 3.125–25 μg/mL CGH. Acid phosphatase in mice peritoneal macrophages was significantly improved after stimulated with CGH at some concentration. The CGH stimulated the secretion of NO from Raw264.7 in a concentration-dependent manner and also significantly inhibited lipopolysaccharide-induced cell excessive activation at some extent. After successive administration of CGH for 21 days, the spleen index of ICR was significantly increased to 3.73 mg/g for the group administrated 800 mg/kg CGH. Malondialdehyde (MDA) assay displayed that 200 mg/kg CGH increased mice serum MDA concentration, while the variation was obsolete in the other CGH groups. All results demonstrated that CGH took essential effects on immunomodulatory activities.